School of Pharmaceutical Sciences, Ohu University.
Faculty of Pharmacy, Yasuda Women's University.
Chem Pharm Bull (Tokyo). 2022;70(2):111-119. doi: 10.1248/cpb.c21-00794.
An efficient synthetic method for novel 4,4-disubstituted 3,4-dihydropyrimidin-2(1H)-ones 5 and -thiones 6 was developed. The cyclocondensation reaction of O-methylisourea hemisulfate salt 11 with 8 gives a tautomeric mixture of dihydropyrimidines 12 and 13 following acidic hydrolysis of the cyclized products to produce 5 in high yields. Thionation reaction of 5 at the 2-position smoothly proceeds to give 2-thioxo derivatives 6. These compounds 5 and 6, corresponding to the products of a Biginelli-type reaction using urea or thiourea, a ketone and a 1,3-dicarbonyl compound, have long been inaccessible and hitherto unavailable for medicinal chemistry. These methods are invaluable for the synthesis of 5 and 6, which have been inaccessible by conventional methods. Therefore, the synthetic methods established in this study will expand the molecular diversity of their related derivatives. These compounds were also assessed for their antiproliferative effect on a human promyelocytic leukemia cell line, HL-60. Treatment of 10 µM 6b and 6d showed high inhibitory activity similarly to 1 µM all-trans retinoic acid (ATRA), indicating that the 2-thioxo group and length of two alkyl substituents at the 4-position are strongly related to activity.
一种新型 4,4-二取代 3,4-二氢嘧啶-2(1H)-酮 5 和 -硫酮 6 的有效合成方法得到了发展。O-甲基异脲半硫酸盐盐 11 与 8 的环缩合反应,在酸性水解环化产物后得到二氢嘧啶 12 和 13 的互变异构混合物,以高产率生成 5。5 在 2-位的硫代反应顺利进行,得到 2-硫代衍生物 6。这些化合物 5 和 6,对应于使用脲或硫脲、酮和 1,3-二羰基化合物的 Biginelli 型反应的产物,长期以来无法获得,且迄今无法用于药物化学。这些方法对于通过常规方法无法获得的 5 和 6 的合成是非常宝贵的。因此,本研究中建立的合成方法将扩展其相关衍生物的分子多样性。还评估了这些化合物对人早幼粒细胞白血病细胞系 HL-60 的抗增殖作用。10 μM 6b 和 6d 的处理表现出与 1 μM 全反式维甲酸 (ATRA) 相似的高抑制活性,表明 2-硫代基团和 4-位两个烷基取代基的长度与活性密切相关。